Companies: 10,795·Total market cap: $144.5T
Ardelyx, Inc.

Ardelyx, Inc.

ARDXNASDAQHealthcare● Active
$5.54
$-0.02(-0.36%)
Market Cap$1.4B
P/E Ratio
52W High$8.4
52W Low$3.49

Ardelyx, Inc.(ARDX)股东结构

基于 13F 申报与流通股数据,展示机构、内部人与公众持股结构;下方为前十大机构、机构动向与内部人交易。

SEC 13F · FMP · ARDX · 截至 2025年9月30日

股东结构概览

机构 65.9%
内部人 4.33%
散户 29.78%

235

机构持有人数

▲ 22 vs Q2

$963.28M

机构持仓总市值

▲ $306.23M vs Q2

247.03M

总流通股

freeFloat 95.67%

162.78M

13F 申报持股数

▼ 4.93M vs Q2

机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源:FMP /symbol-positions-summary + /shares-float + SEC EDGAR。

前10大机构持仓

ARDX 最大股东 · 机构持仓

Q3 2025 · SEC 13F

显示前 10 家

机构持股数占比权重市值申报日变动

BLACKROCK, INC.

pharmaceutical preparations

20.82M8.68%

8.68%

$114.74BNov 12, 2025 75.7K

VANGUARD GROUP INC

pharmaceutical preparations

18.37M7.66%

7.66%

$101.21BNov 7, 2025 2.34M

JANUS HENDERSON GROUP PLC

pharmaceutical preparations

13.82M5.76%

5.76%

$76.14BNov 14, 2025 1.23M

MACQUARIE GROUP LTD

pharmaceutical preparations

10.46M4.36%

4.36%

$57.61BNov 13, 2025 1.00M

STATE STREET CORP

pharmaceutical preparations

9.72M4.05%

4.05%

$53.55BNov 14, 2025 123.2K

MARSHALL WACE, LLP

pharmaceutical preparations

8.94M3.73%

3.73%

$49.28BNov 13, 2025 2.31M

MILLENNIUM MANAGEMENT LLC

pharmaceutical preparations

7.64M3.19%

3.19%

$42.11BNov 14, 2025 4.02M

GEODE CAPITAL MANAGEMENT, LLC

pharmaceutical preparations

5.76M2.40%

2.40%

$31.72BNov 12, 2025 90.7K

NUVEEN, LLC

pharmaceutical preparations

5.17M2.16%

2.16%

$28.51BNov 12, 2025 1.69M

D. E. SHAW & CO., INC.

pharmaceutical preparations

3.31M1.38%

1.38%

$18.25BNov 14, 2025 854.4K

数据来源:SEC 13F 申报文件。变动标识:isNew / isSoldOut / changeInSharesNumber。

机构仓位变动

Q3 2025 对比上季度

Q3 2025

机构整体情绪偏多 — 增持多于减持

26

增持

+14.45M 股

3

新建仓

首次建仓

20

减持

−15.65M 股

0

清仓

完全退出

净股数变化(前50家)

1.20M

+14.45M / −15.65M

净新增持仓人

+9

新建 3 个 / 退出 0 个

基于前50家最大机构持仓统计,全市场实际数量可能不同。

内幕交易买卖情绪

ARDX 内幕交易记录

数据来源:SEC Form 4

买入 0%仅统计主动买卖100% 卖出

近期内部人员以卖出为主。 卖出可能源于预定的 10b5-1 计划,不代表负面展望。

2

买入笔数

23

卖出笔数

0.09

买卖比

$0M

卖出总金额

最近内幕交易记录

最近10条 · 仅普通股

姓名 · 职位日期类型股数价格金额交易后持股申报

Reilly Joseph James

See Remarks

May 21, 2026Sale1,036$6.27$6.5K149.8KForm 4 ↗

Reilly Joseph James

See Remarks

May 21, 2026Sale2,683$6.27$16.8K149.1KForm 4 ↗

Hohenleitner Susan

Chief Financial Officer

May 21, 2026Sale1,455$6.27$9.1K229.1KForm 4 ↗

Bishop John E

See Remarks

May 21, 2026Sale2,306$6.27$14.5K336.8KForm 4 ↗

Brady James Parker

Chief Human Resources Officer

May 21, 2026Sale1,846$6.27$11.6K261.1KForm 4 ↗

Foster Eric Duane

Chief Commercial Officer

May 21, 2026Sale3,166$6.27$19.8K422.8KForm 4 ↗

Foster Eric Duane

Chief Commercial Officer

May 21, 2026Sale2,427$6.27$15.2K420.4KForm 4 ↗

Foster Eric Duane

Chief Commercial Officer

May 21, 2026Sale2,405$6.27$15.1K418.0KForm 4 ↗

Kelliher Mike

Chief Business Officer

May 21, 2026Sale2,900$6.27$18.2K361.8KForm 4 ↗

Kelliher Mike

Chief Business Officer

May 21, 2026Sale1,870$6.27$11.7K359.9KForm 4 ↗

数据来源:SEC Form 4。买卖方向:acquisitionOrDisposition A=买入,D=卖出。已排除 RSU 归属(M-Exempt)。

关于机构与内部人持股结构

Ardelyx, Inc.(ARDX)主要由机构投资者持有,机构持股比例约为 65.9%。公司内部人员持股约 4.33%,散户及公众持股约占剩余的 29.78%。

Ardelyx, Inc. 最大机构股东为 BLACKROCK, INC.,截至 September 30, 2025 持有约 20.82 million 股,占总流通股的 8.68%。

目前共有 235 家机构持有 ARDX 股票,合计持仓市值约 $963,279,964,数据来源为最新 SEC 13F 申报。

常见问题

ARDX ownership

Ardelyx, Inc.(ARDX)主要由机构投资者持有,机构持股约 65.9%。最大股东为 BLACKROCK, INC.,持股比例 8.68%。内部人员持股约 4.33%。数据来源 SEC Form 13F,截至 September 30, 2025。

who owns ARDX stockARDX ownership structureSEC Form 13F institutional holdingsARDX float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025